[ Editorials | Departments and Series | Index ]

 

Editorial JULY 2007


Picking Up All The Pieces

Veronica Ravnikar, MD


The advent of laparoscopic techniques for hysterectomy has made a significant difference in the impact of this procedure. A number of multicenter studies show that such techniques are associated with shorter operative times and quicker recovery/hospital discharge.1,2 There are differences among laparoscopic techniques as well; for example, the laparoscopic supracervical hysterectomy (LSH) with uterine morcellation is considered superior to the laparoscopic assisted vaginal hysterectomy (LAVH) in terms of shorter operative time, less blood loss and postoperative morbidity, and better quality of life.3-5 Indeed, LSH is emerging as the procedure of choice today, and appears to be safer and more efficient—eg, lower complication rates and shorter surgical times compared with LVAH and total abdominal hysterectomy via laparotomy. Insurance providers also favor any procedure that cuts hospital costs.

But how much do we really know about all of the potential outcomes of LSH, especially given that one of its main benefits is speed? For example, there are anecdotal reports of pieces of myometrium left behind in women whose uteri were morcellated, leading to implanted myometrial tissue causing pain and bowel problems.6,7 Some of these cases developed years after the LSH procedure was performed, and so were omitted from initial analyses of outcomes. Surgical correction of these problems is complex because such tissue can cause bowel obstruction, and the retained pieces are more than likely retroperitonealized.7

The published cases involved women with adenomyotic uteri who underwent LSH, suggesting that this form of endometriosis may confer a greater risk of becoming parasitic. Additionally, what about the potential for releasing endometriotic fragments when an ovary with undetected endometriosis is morcellated? And what is the risk of retained ovary syndrome? How will we handle the incidental finding of undiagnosed endometrial cancer in a morcellated uterus? Finally, morcellation certainly creates problems for pathologic evaluation, as the specimen cannot be “oriented.”

Department policies should clearly specify patient criteria for LSH, together with the necessary minimal preoperative work-up. In general, conditions treated effectively by LSH include symptomatic/enlarging fibroids, therapy-resistant abnormal uterine bleeding, and chronic pelvic pain. The patient must have confirmed normal cervical cytology and continue to follow Papanicolaou screening guidelines, and intrauterine/ovarian malignancy must be excluded.

However, the concern remains that the pathologist may still not detect microscopic cancer, or that a known fibroid may be a sarcoma. Furthermore, morcellated fragments can still be left behind inadvertently due to haste, or to the presumption that such fragments will become necrotic.

These procedures must be performed in the right patients, by qualified surgeons, and with the appropriate biopsies. The LSH learning curve for a qualified gynecologist is not long, but varies according to surgical skills and uterine contour/mass. The hospital should clearly define the guidelines for credentialing; centers with large databases suggest that a surgeon needs 80 cases to get the operative time below 90 minutes.4 The complication rate for a specific surgeon does not correlate with the number of cases performed,1-5 so the emphasis should be on caution, not speed. Finally, if there is any suspicion of an abnormality that was not detected beforehand—eg, apparent ovarian endometrioma or dermoid—the procedure should be converted to removal in an endobag, or to an LAVH if the uterine surface is suspicious. In any case, the surgeon should always take the time to pick up all the pieces.

back to top



References

  1. Ewen SP, Sutton CJ. Initial experience with supracervical laparoscopic hysterectomy and removal of the cervical transformation zone. Br J Obstet Gynaecol. 1994;101(3): 225-228.
  2. Hoffman CP, Kennedy J, Borschel L, Burchette R, Kidd A. Laparoscopic hysterectomy; the Kaiser Permanente San Diego experience. J Minim Invasive Gynecol. 2005; 12(1):16-24.
  3. El-Mowafi D, Madkour W, Lall C, Wenger JM. Laparoscopic supracervical hysterectomy versus laparoscopic assisted vaginal hysterectomy. J Am Assoc Gynecol Laparosc. 2004;11(2):175-180.
  4. Bojahr B, Raatz D, Schonleber G, Abri C, Ohlinger R. Perioperative complication rate in 1706 patients after a standardized laparoscopic supracervical hysterectomy technique. J Minim Invasive Gynecol. 2006;13(3):183-189.
  5. Sarmini OR, Lefholz K, Froeschke HP. A comparison of laparoscopic supracervical hysterectomy and total abdominal hysterectomy outcomes. J Minim invasive Gynecol. 2005;12(2):121-124.
  6. Lieng M, Istre O, Busund B, Qvigstad E. Severe complications caused by retained tissue in laparoscopic supracervical hysterectomy. J Minim Invasive Gynecol. 2006;13(3):231-233.
  7. Donnez O, Squifflet J, Leconte I, Jadoul P, Donnez J. Posthysterectomy pelvic adenomyotic masses observed in 8 cases out of a series of 1405 laparoscopic subtotal hysterectomies. J Minim Invasive Gynecol. 2007;14(2):156-160.

back to top


 

 

[ Home | CME/CE | Product News | Author Guidelines ]
[ Editorial Board | Reprints/Permissions | Archives | Circulation | Classifieds | Our Services ]


Copyright ©2000-2010 Quadrant HealthCom Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided on femalepatient.com is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.